Leading Medical Groups Sue Kennedy Over Changed Covid-19 Vaccine Recommendations

Suit argues HHS changed federal guidance outside of established processes, undermining trust

WASHINGTON — Six major medical groups, and a pregnant physician, are suing health secretary Robert F. Kennedy Jr. over changes he made to Covid-19 vaccine recommendations that they say were unlawful and undermine public trust in health care.

The suit argues that a May 19 directive signed by Kennedy, which said that the Covid-19 vaccine would no longer be recommended for healthy children and pregnant people, violates decades of policy governing how vaccines are reviewed, approved, and recommended in the U.S.

“The Secretary cited no emergency, let alone change in circumstances, to justify the directive … [the directive] is contrary to the wealth of data and peer-reviewed studies that demonstrate the safety and efficacy of Covid vaccines for children and pregnant women,” reads the suit, led by the American Academy of Pediatrics and filed Monday in U.S. District Court for the District of Massachusetts.

Other plaintiffs are the American College of Physicians, American Public Health Association, Infectious Diseases Society of America, Massachusetts Public Health Alliance, Society for Maternal-Fetal Medicine, and the pregnant physician. The latter plaintiff, an unnamed woman who works in a Massachusetts hospital, says the policy change has created barriers to getting a Covid-19 vaccine, despite her exposure to illness at work, and has left her worried “for the health and safety of her unborn child,” per the suit.

The new policies described in the May directive from Kennedy — and later unveiled in a video in which he appeared alongside Marty Makary, the commissioner of the Food and Drug Administration, and Jay Bhattacharya, director of the National Institutes of Health — came without involvement of the Centers for Disease Control and Prevention or the panel of vaccine experts that advise federal officials on who should get which vaccine. The CDC has no acting director. 

READ MORE